Pulmonary manifestations of sarcoidosis

Presse Medicale

Volumn 41, Issue 6 PART 2, 2012, Pages

  Baughman, Robert P ^a   Lower, Elyse E ^a   Gibson, Kevin ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; PLACEBO;

AIRWAY OBSTRUCTION; BRONCHIECTASIS; BRONCHIOLE; CLINICAL FEATURE; DISEASE SEVERITY; DYSPNEA; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERMETHOD COMPARISON; LUNG COMPLICATION; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG MYCOSIS; LUNG SARCOIDOSIS; LYMPHADENOPATHY; MUSCLE WEAKNESS; PULMONARY HYPERTENSION; SHORT SURVEY; THORAX RADIOGRAPHY;

EID: 84861948578     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2012.03.019     Document Type: Short Survey

References (79)

1. Loddenkemper R., Kloppenborg A., Schoenfeld N., Grosser H., Costabel U. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis--results of a cooperative study in former West Germany and Switzerland. Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheitan. Sarcoidosis Vasc Diffuse Lung Dis 1998, 15(2):178-182. WATL Study Group.
2. Baughman R.P., Teirstein A.S., Judson M.A., Rossman M.D., Yeager H.J., Bresnitz E.A., et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001, 164:1885-1889.
3. Scadding J.G. Prognosis of intrathoracic sarcoidosis in England. Br Med J 1961, 4:1165-1172.
4. Yeager H., Rossman M.D., Baughman R.P., Teirstein A.S., Judson M.A., Rabin D.L., et al. Pulmonary and psychosocial findings at enrollment in the ACCESS study. Sarcoidosis Vasc Diffuse Lung Dis 2005, 22(2):147-153.
5. Baughman R.P., Shipley R., Desai S., Drent M., Judson M.A., Costabel U., et al. Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation. Chest 2009, 136:526-535.
6. Muers M.F., Middleton W.G., Gibson G.J., Prescott R.J., Mitchell D.N., Connolly C.K., et al. A simple radiographic scoring method for monitoring pulmonary sarcoidosis: relations between radiographic scores, dyspnoea grade and respiratory function in the British thoracic society study of long-term corticosteroid treatment. Sarcoidosis Vasc Diffuse Lung Dis 1997, 14(1):46-56.
7. Hansell D.M., Milne D.G., Wilsher M.L., Wells A.U. Pulmonary sarcoidosis: morphologic associations of airflow obstruction at thin-section CT. Radiology 1998, 209(3):697-704.
8. Hennebicque A.S., Nunes H., Brillet P.Y., Moulahi H., Valeyre D., Brauner M.W. CT findings in severe thoracic sarcoidosis. Eur Radiol 2005, 15(1):23-30.
9. Akbar J.J., Meyer C.A., Shipley R.T., Vagal A.S. Cardiopulmonary imaging in sarcoidosis. Clin Chest Med 2008, 29(3):429-443.
10. Criado E., Sanchez M., Ramirez J., Arguis P., de Caralt T.M., Perea R.J., et al. Pulmonary sarcoidosis: typical and atypical manifestations at high-resolution CT with pathologic correlation. Radiographics 2010, 30(6):1567-1586.
11. Oberstein A., von Zitzewitz H., Schweden F., Muller-Quernheim J. Non-invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography. Sarcoidosis Vasc Diffuse Lung Dis 1997, 14(1):65-72.
12. Baughman R.P., Lower E.E., Tami T. Upper airway, 4: sarcoidosis of the upper respiratory tract (SURT). Thorax 2010, 65(2):181-186.
13. James D.G., Barter S., Jash D., Mackinnon D.M., Carstairs L.S. Sarcoidosis of the upper respiratory tract (SURT). J Laryngol Otol 1982, 96(8):711-718.
14. Panselinas E., Halstead L., Schlosser R.J., Judson M.A. Clinical manifestations, radiographic findings, treatment options, and outcome in sarcoidosis patients with upper respiratory tract involvement. South Med J 2010, 103(9):870-875.
15. Chambellan A., Turbie P., Nunes H., Brauner M., Battesti J.P., Valeyre D. Endoluminal stenosis of proximal bronchi in sarcoidosis: bronchoscopy, function, and evolution. Chest 2005, 127(2):472-481.
16. Shorr A.F., Torrington K.G., Hnatiuk O.W. Endobronchial biopsy for sarcoidosis: a prospective study. Chest 2001, 120(1):109-114.
17. Polychronopoulos V.S., Prakash U.B. Airway involvement in sarcoidosis. Chest 2009, 136(5):1371-1380.
18. Shorr A.F., Torrington K.G., Hnatiuk O.W. Endobronchial involvement and airway hyperreactivity in patients with sarcoidosis. Chest 2001, 120(3):881-886.
19. Young L.M., Good N., Milne D., Zeng I., Kolbe J., Wilsher M.L. The prevalence and predictors of airway hyper-responsiveness in sarcoidosis. Respirology 2012, 1:10-1843.
20. Baughman R.P., Iannuzzi M.C., Lower E.E., Moller D.R., Balkissoon R.C., Winget D.B., et al. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002, 19(3):198-204.
21. Krespi Y.P., Mitrani M., Husain S., Meltzer C.J. Treatment of laryngeal sarcoidosis with intralesional steroid injection. Ann Otol Rhinol Laryngol 1987, 96(6):713-715.
22. Fouty B.W., Pomeranz M., Thigpen T.P., Martin R.J. Dilatation of bronchial stenoses due to sarcoidosis using a flexible fiberoptic bronchoscope. Chest 1994, 106(3):677-680.
23. Sharma O.P., Johnson R. Airway obstruction in sarcoidosis. A study of 123 nonsmoking black American patients with sarcoidosis. Chest 1988, 94(2):343-346.
24. Handa T., Nagai S., Fushimi Y., Miki S., Ohta K., Niimi A., et al. Clinical and radiographic indices associated with airflow limitation in patients with sarcoidosis. Chest 2006, 130(6):1851-1856.
25. Coates R., Neville E. The development of airways obstruction in sarcoidosis among smokers and non-smokers. Sarcoidosis 1993, 10:115-117.
26. Bergin C., Roggli V., Coblentz C., Chiles C. The secondary pulmonary lobule: normal and abnormal CT appearances. AJR Am J Roentgenol 1988, 151(1):21-25.
27. Ploysongsang Y., Roberts R.D. The pathophysiology and response to steroid therapy in sarcoidosis. Respiration 1986, 49(3):204-215.
28. Harrison B.D., Shaylor J.M., Stokes T.C., Wilkes A.R. Airflow limitation in sarcoidosis--a study of pulmonary function in 107 patients with newly diagnosed disease. Respir Med 1991, 85(1):59-64.
29. Ng C.S., Desai S.R., Rubens M.B., Padley S.P., Wells A.U., Hansell D.M. Visual quantitation and observer variation of signs of small airways disease at inspiratory and expiratory CT. J Thorac Imaging 1999, 14(4):279-285.
30. Naccache J.M., Lavole A., Nunes H., Lamberto C., Letoumelin P., Brauner M., et al. High-resolution computed tomographic imaging of airways in sarcoidosis patients with airflow obstruction. J Comput Assist Tomogr 2008, 32(6):905-912.
31. Davies C.W., Tasker A.D., Padley S.P., Davies R.J., Gleeson F.V. Air trapping in sarcoidosis on computed tomography: correlation with lung function. Clin Radiol 2000, 55(3):217-221.
32. Niimi H., Kang E.Y., Kwong J.S., Carignan S., Muller N.L. CT of chronic infiltrative lung disease: prevalence of mediastinal lymphadenopathy. J Comput Assist Tomogr 1996, 20(2):305-308.
33. Toonkel R.L., Borczuk A.C., Pearson G.D., Horn E.M., Thomashow B.M. Sarcoidosis associated fibrosing mediastinitis with resultant pulmonary hypertension: a case report and review of the literature. Respiration 2010, 79(4):341-345.
34. Lengyel R.J., Shanley D.J. Recurrent chylothorax associated with sarcoidosis. Hawaii Med J 1995, 54(12):817-818.
35. Parker J.M., Torrington K.G., Phillips Y.Y. Sarcoidosis complicated by chylothorax. South Med J 1994, 87(8):860-862.
36. Hoitsma E., de Vries J., Santen-Hoeufft M., Faber C.G., Drent M. Impact of pain in a Dutch sarcoidosis patient population. Sarcoidosis Vasc Diffuse Lung Dis 2003, 20(1):33-39.
37. Highland K.B., Retalis P., Coppage L., Schabel S.I., Judson M.A. Is there an anatomic explanation for chest pain in patients with pulmonary sarcoidosis?. South Med J 1997, 90(9):911-914.
38. Bestall J.C., Paul E.A., Garrod R., Garnham R., Jones P.W., Wedzicha J.A. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54(7):581-586.
39. Baughman R.P., Sparkman B.K., Lower E.E. Six-minute walk test and health status assessment in sarcoidosis. Chest 2007, 132(1):207-213.
40. Keir G., Wells A.U. Assessing pulmonary disease and response to therapy: which test?. Semin Respir Crit Care Med 2010, 31(4):409-418.
41. Karetzky M., McDonough M. Exercise and resting pulmonary function in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1996, 13(1):43-49.
42. Steen V., Medsger T.A. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003, 48(2):516-522.
43. Sulica R., Teirstein A.S., Kakarla S., Nemani N., Behnegar A., Padilla M.L. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis related pulmonary hypertension. Chest 2005, 128(3):1483-1489.
44. Baughman R.P., Engel P.J., Meyer C.A., Barrett A.B., Lower E.E. Pulmonary hypertension in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:108-116.
45. Browne P.M., Sharma O.P., Salkin D. Bone marrow sarcoidosis. JAMA 1978, 240:43-50.
46. Lower E.E., Smith J.T., Martelo O.J., Baughman R.P. The anemia of sarcoidosis. Sarcoidosis 1988, 5:51-55.
47. McLoud T.C., Epler G.R., Gaensler E.A., Burke G.W., Carrington C.B. A radiographic classification for sarcoidosis: physiologic correlation. Invest Radiol 1982, 17(2):129-138.
48. Remy-Jardin M., Beuscart R., Sault M.C., Marquette C.H., Remy J. Subpleural micronodules in diffuse infiltrative lung diseases: evaluation with thin-section CT scans. Radiology 1990, 177(1):133-139.
49. Nunes H., Brillet P.Y., Valeyre D., Brauner M.W., Wells A.U. Imaging in sarcoidosis. Semin Respir Crit Care Med 2007, 28(1):102-120.
50. Shigemitsu H., Oblad J.M., Sharma O.P., Koss M.N. Chronic interstitial pneumonitis in end-stage sarcoidosis. Eur Respir J 2010, 35(3):695-697.
51. Pietinalho A., Lindholm A., Haahtela T., Tukiainen P., Selroos O. Inhaled budesonide for treatment of pulmonary sarcoidosis. Results of a double-blind, placebo-controlled, multicentre study. Eur Respir J 1996, 9 (2)(suppl 23):406s.
52. Wallaert B., Talleu C., Wemeau-Stervinou L., Duhamel A., Robin S., Aguilaniu B. Reduction of maximal oxygen uptake in sarcoidosis: relationship with disease severity. Respiration 2011, 82(6):501-508.
53. Nardi A., Brillet P.Y., Letoumelin P., Girard F., Brauner M., Uzunhan Y., et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J 2011, 38(6):1368-1373.
54. Zappala C.J., Desai S.R., Copley S.J., Spagnolo R., Cramer D., Sen D., et al. Optimal scoring of serial change on chest radiography in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2011, 28(2):130-138.
55. Gibson G.J., Prescott R.J., Muers M.F., Middleton W.G., Mitchell D.N., Connolly C.K., et al. British thoracic society sarcoidosis study: effects of long-term corticosteroid treatment. Thorax 1996, 51(3):238-247.
56. Baumann M.H., Strange C., Sahn S.A. Do chest radiographic findings reflect the clinical course of patients with sarcoidosis during corticosteroid withdrawal?. AJR Am J Roentgenol 1990, 154(3):481-485.
57. Drent M., de Vries J., Lenters M., Lamers R.J., Rothkranz-Kos S., Wouters E.F., et al. Sarcoidosis: assessment of disease severity using HRCT. Eur Radiol 2003, 13(11):2462-2471.
58. Vagal A.S., Shipley R., Meyer C.A. Radiological manifestations of sarcoidosis. Clin Dermatol 2007, 25(3):312-325.
59. Nishino M., Lee K.S., Itoh H., Hatabu H. The spectrum of pulmonary sarcoidosis: variations of high-resolution CT findings and clues for specific diagnosis. Eur J Radiol 2010, 73(1):66-73.
60. Lopes A.J., de Menezes S.L., Dias C.M., de Oliveira J.F., Mainenti M.R., Guimaraes F.S. Comparison between cardiopulmonary exercise testing parameters and computed tomography findings in patients with thoracic sarcoidosis. Lung 2011, 189(5):425-431.
61. Abehsera M., Valeyre D., Grenier P., Jaillet H., Battesti J.P., Brauner M.W. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000, 174(6):1751-1757.
62. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-7.
63. Eaton T., Young P., Milne D., Wells A.U. Six-minute walk, maximal exercise tests: reproducibility in fibrotic interstitial pneumonia. Am J Respir Crit Care Med 2005, 171(10):1150-1157.
64. Marcellis R.G., Lenssen A.F., Elfferich M.D., De V.J., Kassim S., Foerster K., et al. Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir J 2011, 38(3):628-634.
65. Baughman R.P., Lower E.E. Six-minute walk test in managing and monitoring sarcoidosis patients. Curr Opin Pulm Med 2007, 13(5):439-444.
66. Bourbonnais J.M., Samavati L. Clinical predictors of pulmonary hypertension in sarcoidosis. Eur Respir J 2008, 32(2):296-302.
67. Ingram C.G., Reid P.C., Johnston R.N. Exercise testing in pulmonary sarcoidosis. Thorax 1982, 37(2):129-132.
68. Mimori Y. Sarcoidosis: correlation of HRCT findings with results of pulmonary function tests and serum angiotensin-converting enzyme assay. Kurume Med J 1998, 45(3):247-256.
69. Foreman M.G., Mannino D.M., Kamugisha L., Westney G.E. Hospitalization for patients with sarcoidosis: 1979-2000. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23(2):124-129.
70. Baughman R.P., Lower E.E. Fungal infections as a complication of therapy for sarcoidosis. QJM 2005, 98:451-456.
71. Ross J.J., Katz J.D. Cryptococcal meningitis and sarcoidosis. Scand J Infect Dis 2002, 34(12):937-939.
72. Shijubo N., Fujishima T., Ooashi K., Morita S., Shigehara K., Nakata H., et al. Pulmonary cryptococcal infection in an untreated patient with sarcoidosis. Sarcoidosis 1995, 12(1):71-74.
73. Allen K.S., Glickstein M., Arger P.H., Bilaniuk L., Levy D.W. Cryptococcosis associated with sarcoidosis: CT and MR findings. J Comput Assist Tomogr 1988, 12(3):420-422.
74. Waldhorn R.E., Tsou E., Kerwin D.M. Invasive pulmonary aspergillosis associated with aspergilloma in sarcoidosis. South Med J 1983, 76(2):251-253.
75. Pena T.A., Soubani A.O., Samavati L. Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature. Lung 2011, 189(2):167-172.
76. Marchiori E, Zanetti G, Escuissato DL, Souza AS, Jr., Meirelles GD, Fagundes J et al. Reversed halo sign: high-resolution CT findings in 79 patients. Chest 2011; 11-105. doi:10.1378/chest.
77. Nunes H., Humbert M., Capron F., Brauner M., Sitbon O., Battesti J.P., et al. Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis. Thorax 2006, 61(1):68-74.
78. Baughman R.P., Engel P.J., Taylor L., Lower E.E. Survival in sarcoidosis associated pulmonary hypertension: the importance of hemodynamic evaluation. Chest 2010, 138:1078-1085.
79. Baughman R.P., Costabel U., du Bois R.M. Treatment of sarcoidosis. Clin Chest Med 2008, 29(3):533-548.